Risk and What It Means to the Pharmaceutical Industry

Curran, Laura (2022) Risk and What It Means to the Pharmaceutical Industry. Masters thesis, Dublin, National College of Ireland.

Preview

PDF (Master of Business) Download (732kB) | Preview

Abstract

In today’s business climate, risk is key to creating and maintaining turnover within all industries. The term risk has long been researched on the perception of risk among people in both generic and specific disciplines, with no consensus on the definition of “risk” within the risk community.

This study aims to identify what risk means to the pharmaceutical industry, how it uses risk, and the effect of company culture on risk. There is no possible way to manage a company successfully without successfully managing its risks, with this study further investigating if utilising a risk framework would be beneficial to an organisation’s management of risk.

The author has taken a mono method approach to this study, conducting seven semi-structured interviews, using qualitative data collection analysis. The approach allowed for an inductive method to be applied and deduce from the data findings to fill the research gaps identified in this study.

Item Type:	Thesis (Masters)
Subjects:	H Social Sciences > HD Industries. Land use. Labor > HD61 Risk Management R Medicine > RS Pharmacy and materia medica
Divisions:	School of Business > Master of Business Administration
Depositing User:	Clara Chan
Date Deposited:	05 Oct 2022 11:13
Last Modified:	05 Oct 2022 11:13
URI:	https://norma.ncirl.ie/id/eprint/5801

Actions (login required)

View Item